BioMarin Reports Strong Second Quarter 2025 Results and Raises Full-year Guidance¹ for Total Revenues, Non-GAAP Operating Margin, and Non-GAAP Diluted EPSPRNewsWire • 08/04/25
BioMarin Pharmaceutical (BMRN) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research • 07/28/25
BioMarin to Host Second Quarter 2025 Financial Results Conference Call and Webcast on Monday, August 4, 2025, at 4:30pm ETPRNewsWire • 07/22/25
Looking for a Growth Stock? 3 Reasons Why BioMarin (BMRN) is a Solid ChoiceZacks Investment Research • 07/16/25
Wall Street Analysts Think BioMarin (BMRN) Could Surge 70.77%: Read This Before Placing a BetZacks Investment Research • 07/16/25
Nasdaq Bull Market: 3 Historically Cheap Stocks That Can Easily Double Your MoneyThe Motley Fool • 07/16/25
Will BioMarin (BMRN) Beat Estimates Again in Its Next Earnings Report?Zacks Investment Research • 07/10/25
BioMarin Presents Five-Year Phase 3 Results Reinforcing Long-Term Efficacy and Safety of ROCTAVIAN® (valoctocogene roxaparvovec-rvox) at International Society on Thrombosis and Haemostasis 2025 CongressPRNewsWire • 06/24/25
Is the Options Market Predicting a Spike in BioMarin Pharmaceutical Stock?Zacks Investment Research • 05/28/25
INOZYME PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inozyme Pharma, Inc. - INZYBusiness Wire • 05/21/25
BioMarin Offers to Buy Inozyme for $270M to Boost Enzyme Therapy BizZacks Investment Research • 05/19/25
How BioMarin's $270 Million Takeover Led This Dollar Stock To A Triple-Digit GainInvestors Business Daily • 05/16/25
BioMarin Presents New Data for VOXZOGO® (vosoritide) in Children with Achondroplasia and Other Skeletal Conditions at Two International Endocrinology MeetingsPRNewsWire • 05/12/25
BioMarin (BMRN) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 05/02/25
BioMarin Pharmaceutical (BMRN) Beats Q1 Earnings and Revenue EstimatesZacks Investment Research • 05/01/25
BioMarin to Host First Quarter 2025 Financial Results Conference Call and Webcast on Thursday, May 1, 2025, at 4:30pm ETPRNewsWire • 04/17/25